Evaluation of Serum Amyloid A Levels in Celiac Disease

Cakmak R., EKMEN N., KAVUTÇU M., GÜLBAHAR Ö., ARHAN M.

MEDICAL JOURNAL OF BAKIRKOY, cilt.17, sa.3, ss.248-253, 2021 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/bmj.galenos.2021.32932
  • Dergi Adı: MEDICAL JOURNAL OF BAKIRKOY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.248-253
  • Anahtar Kelimeler: Celiac disease, serum amyloid A, C-reactive protein, RHEUMATOID-ARTHRITIS, A-PROTEIN, VITAMIN-D, RISK
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: In celiac disease (CD), gluten intake triggers the release of T-cell-derived pro-inflammatory cytokines leading to an increase in the level of serum amyloid A (SAA). To confirm inflammation caused by CD in patients, SAA level is expected to be a better biomarker candidate than C-reactive protein (CRP). This study investigated the relationship between clinical and biochemical variables used in the follow-up of CD patients and SAA levels.